Literature DB >> 1771257

Time-dose factors in positive neck nodes treated with irradiation only.

J M Taylor1, W M Mendenhall, R S Lavey.   

Abstract

This article describes an analysis of time-dose and clinical factors which affect the 2 year rate of control of cervical node metastases from squamous cell carcinoma of the head and neck following external beam radiotherapy in a series of 140 patients. We find that node diameter and normalized total dose are the most important factors, and that overall treatment time is not statistically significant.

Entities:  

Mesh：

Year:  1991        PMID： 1771257     DOI： 10.1016/0167-8140(91)90020-h

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  4 in total

1.  Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma.

Authors:  R B J de Bondt; M C Hoeberigs; P J Nelemans; W M L L G Deserno; C Peutz-Kootstra; B Kremer; R G H Beets-Tan
Journal:  Neuroradiology       Date:  2009-01-10       Impact factor: 2.804

2.  Morphological MRI criteria improve the detection of lymph node metastases in head and neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cervical lymph nodes.

Authors:  R B J de Bondt; P J Nelemans; F Bakers; J W Casselman; C Peutz-Kootstra; B Kremer; P A M Hofman; R G H Beets-Tan
Journal:  Eur Radiol       Date:  2008-10-07       Impact factor: 5.315

3.  The role of 3 Tesla diffusion-weighted imaging in the differential diagnosis of benign versus malignant cervical lymph nodes in patients with head and neck squamous cell carcinoma.

Authors:  Flavio Barchetti; Nicola Pranno; Guglielmo Giraldi; Alessandro Sartori; Silvia Gigli; Giovanni Barchetti; Luigi Lo Mele; Luigi Tonino Marsella
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

4.  Tumor Volumes and Prognosis in Laryngeal Cancer.

Authors:  Mohamad R Issa; Stuart E Samuels; Emily Bellile; Firas L Shalabi; Avraham Eisbruch; Gregory Wolf
Journal:  Cancers (Basel)       Date:  2015-11-10       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.